Recent Articles from GlobeNewswire

Berlin, Germany, October 18, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced a higher objective response rate (ORR) and prolonged median progression-free survival (mPFS) across subgroups in patients treated with non-carrier-added (n.c.a) 177Lu-edotreotide (also known as ITM-11 or 177Lu-edotreotide) compared to everolimus from its Phase 3 COMPETE trial in Grade 1 or Grade 2 somatostatin receptor (SSTR)-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Study investigator Jaume Capdevila, MD, PhD, presented the data in an oral presentation at the European Society for Molecular Oncology (ESMO) Congress, held October 17-21, 2025 in Berlin, Germany.

SAN FRANCISCO, Oct. 18, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced updated data from the Phase 1b/2 study of palazestrant in combination with ribociclib in patients with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. These findings will be presented in a poster session on October 20 at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany.

MEXICO CITY, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroméxico, S.A.B. de C.V. (“Aeroméxico”) today announced the launch of its global offering (the “Global Offering”), consisting of 11,727,325 American Depositary Shares (“ADSs”) in the United States and 27,463,590 common shares in Mexico. Each ADS represents 10 common shares of Aeroméxico.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- StoneX Group Inc. (NASDAQ: SNEX), a global financial services firm connecting clients to the markets across asset classes and geographies, today announced it has completed its acquisition of Intercam Advisors, Inc. and Intercam Securities, Inc., —U.S.-based firms providing brokerage and investment advisory services to Latin American clients.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Baxter International, Inc. (“Baxter” or the “Company”) (NYSE:BAX) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

WILMINGTON, Mass., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Beginning with the fourth quarter and year ended August 30, 2025, UniFirst Corporation (the “Company,” “we,” or “our”) will be changing the structure of its reporting organization, which will result in corresponding changes to the Company’s financial operating and reportable segments. 

SAN DIEGO, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Tronox Holdings PLC (NYSE: TROX) common stock between February 12, 2025 and July 25, 2025. Tronox operates titanium-bearing mineral sand mines and processes them to produce titanium dioxide (TiO2) products. The complaint alleges that Tronox failed to disclose the truth about its business prospects.

SAN CARLOS, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on October 16, 2025 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 62,790 shares of Iovance’s common stock to nine new, non-executive employees.

MONTREAL, Oct. 17, 2025 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), the leader in innovating for ultra-high temperature processes and engineering, and a technology provider to heavy industry & defense, announces today that up to 1,581,250 common share purchase warrants (the “Warrants”) will be amended.

BUKIT MERTAJAM, MALAYSIA, Oct. 17, 2025 (GLOBE NEWSWIRE) -- CCH Holdings Ltd (the “Company”), a Malaysia-based specialty hotpot restaurant chain, today announced that the underwriters of its previously announced initial public offering (the “Offering”), which closed on October 6, 2025, have exercised their over-allotment option (the “Over-Allotment Option”) in full to purchase an additional 187,500 ordinary shares at the public offering price of US$4.00 per ordinary share resulting in additional gross proceeds of US$750,000, before deducting the estimated underwriting discounts and commissions, non-accountable expense allowance, and estimated offering expenses payable by the Company. After giving effect to the full exercise of the Over-Allotment Option, the total number of ordinary shares sold by the Company in the Offering increased to 1,437,500 ordinary shares and the gross proceeds increased to US$5,750,000, before deducting the estimated underwriting discounts and commissions, non-accountable expense allowance, and estimated offering expenses payable by the Company. The closing of the exercise of the Over-Allotment Option occurred on October 17, 2025. The Company’s ordinary shares began trading on the Nasdaq Capital Market under the symbol “CCHH” on October 3, 2025.

SAN DIEGO, Oct. 17, 2025 (GLOBE NEWSWIRE) --

SAN DIEGO, Oct. 17, 2025 (GLOBE NEWSWIRE) --

SAN ANTONIO, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT) a leading end-to-end hybrid cloud and AI solutions company, today announced that it will release its third quarter 2025 financial results after the market closes on Thursday, November 6th, 2025. Gajen Kandiah, Chief Executive Officer, and Mark Marino, Chief Financial Officer, will host a conference call on the day of the release (November 6, 2025) at 5:00 PM ET to discuss the Company’s financial results.

TORONTO, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), the leading sportsbook and iGaming operator for digital-first players, today announces that it has closed the second tranche of its non-brokered private placement (the “Private Placement”) previously announced on September 29, 2025. The Company issued 27,600,000 units (“Units”) at a price of C$0.05 per Unit, for gross proceeds of C$1,380,000. Each Unit consists of one (1) subordinate voting share in the capital of the Company (each, a "SV Share") and one (1) SV Share purchase warrant (each, a "Warrant"). Each Warrant is exercisable into one (1) SV Share (each, a "Warrant Share") at a price of C$0.10 per Warrant Share until October 8, 2027. The SV Shares, Warrants and Warrant Shares are subject to a four-month statutory hold period, in accordance with applicable securities legislation. The Company intends to use the proceeds from the Private Placement for corporate development and general working capital purposes.

TORONTO, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Onex Canada Asset Management Inc. (the “Manager”) today announced it intends to terminate Onex Global Equity Fund (formerly, Onex International Fund) (the “Fund”) on or about December 29, 2025.

Agrees to Board Size Reduction and Certain Director Compensation Limitations; Star Equity Withdraws Nominations

Lima, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Lima, PERU, October 17th, 2025 - Credicorp Ltd. (“Credicorp”) (NYSE: BAP | BVL: BAP) announces that in accordance with its corporate disclosure policies and to prevent any leaks of financial results and ensure fairness, the Company will start the quiet period for 3Q25’s earnings release on October 30th. This period will end on the date of the release, November 13th. During the quiet period, the Company will not disclose any financial information, comment on financial results, or respond to related questions.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Value Line, Inc. (NASDAQ: VALU) announced today that its Board of Directors declared on October 17, 2025 a quarterly cash dividend of $0.325 per common share, payable on November 10, 2025, to stockholders of record on October 27, 2025. The Company has 9,405,828 shares of common stock outstanding as of October 17, 2025.

LIBERTY, Mo., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Ferrellgas, L.P. (the “Company”) and its wholly-owned subsidiary Ferrellgas Finance Corp. (together with the Company, the “Issuers”) announced today that the Issuers priced an offering of $650.0 million aggregate principal amount of 9.250% senior notes due 2031 (the “Notes”) at an offering price equal to 100% of the principal thereof. The offering of the Notes is expected to close on or about October 27, 2025, subject to customary closing conditions.

EMERYVILLE, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on October 14, 2025, the compensation committee of the Company’s board of directors granted three new non-executive employees 25,450 Restricted Stock Units (RSUs). The RSUs were granted pursuant to the Company’s 2025 Employment Inducement Award Plan, which was approved by the Company’s board of directors in February 2025 under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into employment with the Company.

SAN FRANCISCO and VANCOUVER, British Columbia, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“the Company” or “Jade”), (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced that it will present new preclinical safety and translational data for JADE101, its lead investigational candidate for immunoglobulin A nephropathy (IgAN), during two poster sessions at the American Society of Nephrology (ASN) Kidney Week 2025, taking place November 5–9 in Houston, Texas.

MotorTrend Head of Editorial Ed Loh Shares Exclusive Insights on This Year’s Winner: the Volkswagen Golf GTI and R

COMPLETE DIGITAL CATALOG FOR OCTOBER 31 AUCTION NOW LIVE | INAUGURAL SALE LED BY BUGATTI VEYRON EB 16.4 COUPE, MERCEDES-BENZ 300 SL ROADSTER, AND A HOST OF MODERN COLLECTIBLES

An interactive billboard challenged the myth that antivirus software provides complete digital protection

Key Highlights

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) --

Admissions, Contradictions, and Intelligent AI Assistant Now Accessible Directly From Each Deposition Insights™ Summary

Blue & Bold aims to empower students, advance research and elevate communities

OXFORD, United Kingdom, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Installed desalination capacity has grown by 40% since 2020, while global water reuse capacity has surged by 52% over the same period, according to findings from the newly released IDRA Desalination & Reuse Handbook 2025–2026.

CHENNAI, India, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Sify Infinit Spaces Limited (“SISL”), a wholly owned subsidiary of Sify Technologies Limited (“Sify”), publicly filed a draft red herring prospectus on October 17, 2025 with the Securities and Exchange Board of India, BSE Limited, and the National Stock Exchange of India Limited, in connection with its proposed Initial Public Offering (IPO) of equity shares of face value ₹10 each (“Equity Shares”).

New York, NY, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Interpublic Group (NYSE: IPG) today announced that it expects to file its quarterly report on Form 10-Q for the quarter ended September 30, 2025 with the U.S. Securities and Exchange Commission with its third quarter 2025 financial results on or before November 10, 2025.

The industry leader’s AI-Powered Advertising Review solution earns distinction for advancing marketing compliance through automation and continuous innovation

RANCHO CORDOVA, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”), a holding company that operates through its wholly owned banking subsidiary, Five Star Bank (the "Bank"), announced today the declaration of a cash dividend of $0.20 per share on the Company’s voting common stock. The dividend is expected to be paid on November 10, 2025, to shareholders of record as of November 3, 2025.

Transaction in Own Shares   

SAN FRANCISCO, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Sagehood.ai announced live production results for its Agentic AI Index, delivering an outstanding 38% year-to-date return through October 4, 2025 — outperforming most asset managers and hedge funds globally.

New York, NY, Oct. 17, 2025 (GLOBE NEWSWIRE) -- GSR IV Acquisition Corp. (“GSRF” or the “Company”) announced today that, commencing October 20, 2025, holders of the units sold in the Company’s initial public offering of 23,000,000 units, which included 3,000,000 units issued upon the full exercise of the underwriter’s over-allotment option (“Units”), may elect to separately trade the Company’s Class A Ordinary Shares (“Class A Ordinary Shares”) and Rights (Rights”) included in the Units. Each Unit consists of one Class A Ordinary Share and one-seventh (1/7th) of one Right, with each whole right entitling the holder thereof to receive one Class A Ordinary Share upon the consummation of an initial business combination. No fractional rights will be issued upon separation of the units and only whole rights will trade. The Class A Ordinary Shares and Rights that are separated will trade on Nasdaq Global Market (“Nasdaq”) under the symbols “GSRF” and “GSRFR,” respectively. Those units not separated will continue to trade on Nasdaq under the symbol “GSRFU.” Holders of units will need to have their brokers contact Odyssey Transfer and Trust Company, the Company’s transfer agent, in order to separate the units into Class A Ordinary Shares and Rights.

Memphis, TN, Oct. 17, 2025 (GLOBE NEWSWIRE) -- The National Civil Rights Museum at the Lorraine Motel celebrated courage, compassion, and leadership at its 34th Annual Freedom Award ceremony, honoring three transformative figures whose work continues to shape the modern struggle for justice and equality.

Washington, DC, Oct. 17, 2025 (GLOBE NEWSWIRE) -- The following statement, issued jointly by the American Association of Colleges and Universities and the Phi Beta Kappa Society, was developed in collaboration with college and university presidents and other educational leaders across the country.

CALGARY, Alberta, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Eavor Technologies Inc. is pleased to announce the appointment of Mark Fitzgerald as its new President and Chief Executive Officer, effective October 20, 2025.

Woburn, MA, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved FerabrightTM (ferumoxytol injection), the first and only iron-based contrast agent indicated for magnetic resonance imaging (MRI) of the brain in adults with known or suspected malignant neoplasms in the brain to visualize lesions with a disrupted blood-brain barrier.1

BOSTON, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Today, Flywire Corporation (Flywire) (Nasdaq: FLYW), a global payments enablement and software company, announced that its third-quarter financial results will be released after market close on Tuesday, November 4, 2025. Flywire will host a conference call to discuss its third-quarter financial results at 5:00 pm ET the same day. Hosting the call will be Mike Massaro, CEO, Rob Orgel, President and COO, and Cosmin Pitigoi, CFO.

- Amendment includes finalized cash amount and updated CVR terms for tender offer

Raleigh, N.C., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Wake Radiology UNC Health Rex, the largest outpatient imaging provider in the Triangle, today announced the continued expansion of its breast imaging section with the addition of five new board-certified radiologists over the past year. The radiologists join the practice at a time when the demand for breast imaging is anticipated to grow, as a larger segment of the population reaches the recommended age of 40, the age at which the American College of Radiology and the Society of Breast Imaging advise women to begin annual screening mammograms.

SINGAPORE, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Davis Commodities Limited (Nasdaq: DTCK), a Singapore-based agricultural trading and digital finance company, disclosed today that it is evaluating an expansion strategy for its ESG-certified agri-trade ecosystem, potentially linking over USD 500 million in sustainable commodity flows across Asia and Africa within the next three years.

Company announcement – No. 22 / 2025

From Hot Flashes to Brain Fog: Menopause and Perimenopause Symptoms Explained—and What You Can Do

ANN ARBOR, Mich., Oct. 17, 2025 (GLOBE NEWSWIRE) -- The National Center for Manufacturing Sciences (NCMS) announces the publication of a new Technology Brief that demonstrates how artificial intelligence (AI) and machine learning (ML) are being used to supersize the benefits of predictive maintenance.

Hong Kong, Oct. 17, 2025 (GLOBE NEWSWIRE) -- ACCO GROUP HOLDINGS LIMITED (“ACCL” or the “Company”), a corporate services provider headquartered in Hong Kong, today announced the pricing of its initial public offering (the “Offering”) of 1,400,000 ordinary shares (the “Ordinary Shares”) at the price of $4.00 per Ordinary Shares (the “Offering Price”). The Ordinary Shares are expected to commence trading on the Nasdaq Capital Market on October 17, 2025 under the ticker symbol “ACCL.” The Offering is expected to close on October 20, 2025, subject to the satisfaction of customary closing conditions.

SOUTH SAN FRANCISCO, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Silver Creek Pharmaceuticals, Inc. (Silver Creek), a clinical-stage biotechnology company developing growth factor-based therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to scp776, its investigational therapy for acute ischemic stroke, a condition with limited treatment options beyond reperfusion.

Annual event raises over $1 million in scholarship funds for local students, with $100,000 contribution from Supervisor Curt Hagman and support from Vendor Community

Ingelheim, Germany / Ridgefield, Connecticut, U.S.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Altamirano PLLC, a New York-based securities arbitration law firm, has announced an investigation into the brokerage firms that sold Inspired Healthcare Capital (IHC) investments.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against RCI Hospitality Holdings, Inc. (“RCI” or the “Company”) (NASDAQ: RICK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against WPP Plc (“WPP” or the “Company”) (NYSE: WPP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Quanex Building Products Corporation (“Quanex” or the “Company”) (NYSE: NX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in KBR, Inc. of, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against KBR, Inc. (“KBR” or the “Company”) (NYSE: KBR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate (“Cytokinetics” or the “Company”) (NASDAQ: CYTK).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fly-E Group, Inc. (“Fly-E” or the “Company”) (NASDAQ: FLYE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against VF Corporation (“VFC” or the “Company”) (NYSE: VFC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Tronox Holdings Plc (“Tronox” or the “Company”) (NYSE: TROX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Quantum Corporation (“Quantum” or the “Company”)(NASDAQ: QMCO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Jasper Therapeutics, Inc.  (“Jasper” or the “Company”) (NASDAQ: JSPR) and certain officers.   The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08010, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Jasper securities between November 30, 2023 and July 3, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against C3.ai, Inc. (“C3” or the “Company”) (NYSE: AI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against PubMatic, Inc. (“PubMatic” or the “Company”) (NASDAQ: PUBM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fluor Corporation (“Fluor” or the “Company”) (NYSE: FLR) and certain officers.   The class action, filed in the United States District Court for the Northern District of Texas, Dallas Division, and docketed under 25-cv-02496, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fluor securities between February 18, 2025 and July 31, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA) and certain officers.   The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 25-cv-05147, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Savara securities between March 7, 2024 and May 23, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Dow Inc. (“Dow” or the “Company”) (NYSE: DOW) and certain officers. The class action, filed in the United States District Court for the Eastern District of Michigan, Northern Division, and docketed under 25-cv-12744, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Dow securities between January 30, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) and certain officers.   The class action, filed in the United States District Court for the Southern District of Texas, and docketed under 25-cv- 03999, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nutex securities between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.